# Kazakh Association of Internal Medicine Specialists: Observational study in Metabolic Dysfunction-Associated Steatotic Liver Disease (420 participants)

**Score:** 55/100

| Field | Value |
|---|---|
| Sponsor | Kazakh Association of Internal Medicine Specialists |
| Sponsor type | Academic and hospital |
| Study | Clinical Profile of Patients With MASLD in Kazakhstan and Clinical Effectiveness of Ursosan in Almaty |
| NCT ID | NCT07889999 |
| Phase | Observational |
| Status | recruiting |
| Conditions | Metabolic Dysfunction-Associated Steatotic Liver Disease |
| Target enrollment | 420 |
| Site countries | Kazakhstan |
| Posted | 2026-10-22 |
| Planned start | 2026-08-12 |
| Event | Newly registered study |
| Event date | 2026-10-22 |

## Why this score
- Posted in the last two weeks.
- 420 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07889999). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.